Search research articles
Contact Us
Filters
Showing results (21-30 of 77) with videos related to
Page
of 8
Sort By:
Internal Medicine Journal
|
October 24, 2009
Intraperitoneal distribution imaging in ovarian cancer patients
S J Dawson, R J Hicks, V Johnston, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide
L K Webster, M E Linsenmeyer, D Rischin, et al.
Gynecologic Oncology
|
May 2, 2001
Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I study
H M Prince, D Rischin, M Quinn, et al.
Pathology
|
July 1, 1993
Rectal adenocarcinoma with germ cell elements treated with chemotherapy
A G Ostör, W M McNaughton, D W Fortune, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
April 1, 1998
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix
N Tebbutt, D Rischin, M Quinn, et al.
British Journal of Cancer
|
August 17, 2000
A phase II trial of paclitaxel and epirubicin in advanced breast cancer
D Rischin, J Smith, M Millward, et al.
Gynecologic Oncology
|
November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01
A V Tinker, V Gebski, B Fitzharris, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 23, 2001
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study
M Poulsen, D Rischin, E Walpole, et al.
Gynecologic Oncology
|
October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel
J D Shapiro, M J Millward, D Rischin, et al.
American Journal of Clinical Oncology
|
October 1, 1992
A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer
D Rischin, J F Bishop, I N Olver, et al.
Page
of 8
Search research articles
Search
Showing results (21-30 of 77) with videos related to
Sort By:
Page
of 8
Internal Medicine Journal
|
October 24, 2009
Intraperitoneal distribution imaging in ovarian cancer patients
S J Dawson, R J Hicks, V Johnston, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1997
Plasma concentrations of polysorbate 80 measured in patients following administration of docetaxel or etoposide
L K Webster, M E Linsenmeyer, D Rischin, et al.
Gynecologic Oncology
|
May 2, 2001
Repetitive high-dose topotecan, carboplatin, and paclitaxel with peripheral blood progenitor cell support in previously untreated ovarian cancer: results of a Phase I study
H M Prince, D Rischin, M Quinn, et al.
Pathology
|
July 1, 1993
Rectal adenocarcinoma with germ cell elements treated with chemotherapy
A G Ostör, W M McNaughton, D W Fortune, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology
|
April 1, 1998
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix
N Tebbutt, D Rischin, M Quinn, et al.
British Journal of Cancer
|
August 17, 2000
A phase II trial of paclitaxel and epirubicin in advanced breast cancer
D Rischin, J Smith, M Millward, et al.
Gynecologic Oncology
|
November 3, 2006
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01
A V Tinker, V Gebski, B Fitzharris, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 23, 2001
Analysis of toxicity of Merkel cell carcinoma of the skin treated with synchronous carboplatin/etoposide and radiation: a Trans-Tasman Radiation Oncology Group study
M Poulsen, D Rischin, E Walpole, et al.
Gynecologic Oncology
|
October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxel
J D Shapiro, M J Millward, D Rischin, et al.
American Journal of Clinical Oncology
|
October 1, 1992
A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer
D Rischin, J F Bishop, I N Olver, et al.
Page
of 8